Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?

Authors

  • Kechiche Nahla
  • Makhlouf Dorsaf
  • Belhassen Samia
  • Hmidi Nahla
  • Lamiri Rachida
  • Mekki Mongi
  • Belguith Mohssen
  • Nouri Abdellatif

Keywords:

Congenital mesoblastic nephroma, Recurrence, Adjuvant therapy, Neonate

Abstract

Congenital mesoblastic nephroma (CMN) is a rare renal tumor of infancy. Complete surgical excision is often sufficient. A premature neonate underwent left radical nephrectomy for CMN without any adjuvant therapy. Pathology was consistent with cellular type CMN. Six months postoperatively, the patient developed recurrence. He subsequently underwent re-excision without any adjuvant chemotherapy. The baby is tumor free for more than a year.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2019-12-27

How to Cite

1.
Nahla K, Dorsaf M, Samia B, Nahla H, Rachida L, Mongi M, Mohssen B, Abdellatif N. Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?. J Neonatal Surg [Internet]. 2019Dec.27 [cited 2021Mar.1];8(3):22. Available from: https://jneonatalsurg.com/ojs/index.php/jns/article/view/242

Most read articles by the same author(s)